Skip to main content

Table 3 Risk factors for interstage mortality in heterotaxy syndrome with functional single ventricle

From: Interstage mortality for functional single ventricle with heterotaxy syndrome: a retrospective study of the clinical experience of a single tertiary center

  Univariate Cox analysis (P value) Multivariate Cox analysis
P value HR 95% CI
Male 0.503    
Isomerism 0.971    
BCPS as the 1st palliation 0.05 0.062 24.4 0.85-699.44
Low Birth weight (<3p) 0.186 0.055 12.7 0.95-170.10
Low Body weight (<3p) at discharge 0.003 0.781 0.7 0.06-7.56
AVVR > mild 0.111 0.373 0.4 0.07-2.68
Pulmonary atresia 0.262    
Pulmonary vein stenosis at diagnosis 0.089 0.019 56.5 1.96-1630.41
Duration of hospitalization (days) 0.225 0.004 0.8 0.75-0.94
Duration of ICU care (days) 0.055 0.051 1.3 0.99-1.82
Duration of mechanical ventilation (days) 0.040 0.590 0.9 0.78-1.14
Duration of IV inotropics (days) 0.044 0.065 0.8 0.66-1.01
Duration of TPN (days) 0.103 0.116 1.2 0.95-1.55
Antiarrhythmic at discharge 0.590    
Digoxin at discharge 0.617    
Oxygen saturation at discharge (%) 0.002 0.089 0.8 0.66-1.03
  1. BCPS bidirectional cavo-pulmonary shunt, AVVR atrioventricular valve regurgitation, ICU intensive care unit, IV intravenous, TPN total parenteral nutrition.